Name:Priv.-Doz. Dr. med. Mark Rosenberg
Affiliation: UniversityMedicalCenter Schleswig-Holstein (SH), Campus Kiel,
Internal Medicine III (Cardiology and Angiology), Schittenhelmstr. 12, 24105 Kiel, Germany
Phone:+49 (0)431 5971405
Fax:+49 (0)431 5971470
e-mail:
Personal data
Date of birthAugust 7th, 1973
Place of birthMannheim
Marital statusMarried, 2 children
CitizenshipGerman
Education and scientific training:
1993-2000Ruprecht-Karls-University Heidelberg, MedicalSchool
1999HarvardMedicalSchool, Subinternship Internal Medicine
1999Mount Sinai HospitalNew York, Subinternship Cardiology
2000Graduation from MedicalSchool
2001Completion of doctoral thesis in experimental heart surgery
2013Venia legendi for internal medicine (Associate Professor)
United States Medical Licensing Examination
1997Step 1
1999Step 2
Professional career:
2000-2008Research Fellow and Residency in Internal Medicine and Cardiology at the
University ofHeidelberg (2000-2002 Prof. Dr. Kübler; 2002-2008 Prof. Dr.
Katus)
2006-2008Interventional Fellow at the UniversityHospital of Heidelberg
24.06.2008Board Certification “Internal Medicine”
18.09.2008Board Certification “Cardiology”
01.10.2008Attending Physician, Internal Medicine III (Cardiology and Angiology), University Medical Center SH, Campus Kiel
01.10.2009Head Interventional Cardiology, UniversityMedicalCenter SH, Campus Kiel
01.01.2010Head Intensive Care Unit, UniversityMedicalCenter SH, Campus Kiel
01.07.2012Implementation and Head of a Chest Pain Unit, University Medical Center SH, Campus Kiel, certified by the German Society of Cardiology
01.07.2012Deputy Director,Internal Medicine III (Cardiology and Angiology), University Medical Center SH, Campus Kiel
20.12.2014Certified Interventional Cardiologist of the German Society of Cardiology
10.03.2015Deputy Director of the certified training center for interventional cardiology at the University Medical Center Schleswig-Holstein, Campus Kiel
Specific Expertise:
01.12.2010Implementation of a dedicated programm for the interventional reconstruction of the mitral valve using the MitraClip system
01.07.2011Implementation of a dedicated program for the recanalization of chronically occluded coronary arteries (CTO)
25.01.2012Upgrade Training Course for the use of bioresorbable vascular scaffolds (BVS)
04.07.2012Upgrade Training Course for the use of bifurcation stent systems
01.08.2013Implementation of a dedicated program for the use of extracorporal life support systems (ECLS) and Impella system.
Interventional Study Experience
Local Principal investigator MELODY study
Local Principal Investigator RESHAPE study
Co-Principal Investigator “DEB only All comers Registy”
Co-Principal Investigator “Use of BL-1040 in the treatment of an acute myocardial
infarction”
Co Investigator “ABSORB: Postmarketing Surveillance Registry to Monitor the
Everolimus-eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (ASSURE)”
Co Investigator Restore I and II trial
Co Investigator Preservation trial
Member of the CEC Committee for the E-Biomatrix Registry
Faculty Member ASIA PCR and EuroPCR 2014 and 2015
Awards:
2007Poster Price German Society of Internal Medicine
2010Actelion Poster Price Update Pulmonary Hypertension
Patents:
US Patent Application 20100267062 – Osteopontin as a novel prognostic Biomarker for Heart Failure
Memberships:
German Society of Internal Medicine (DGIM)
German Society of Cardiology (DGK)
Working Group on Interventional Cardiology of the German Society of Cardiology (AGIK)
Working Group on recanalization of chronic total occlusions (CTO) of the AGIK
European Association of Percutaneous Cardiovascular Intervention (EAPCI)
Kiel, 9th of September 2015
Priv.-Doz. Dr. Mark Rosenberg